Yes. If they need independent reviewers to tell them that investors don't like companies that make a loss, they should pay for the review themselves. Instead, us investors end up paying for the review to tell them why they are on the nose.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game